Your browser doesn't support javascript.
loading
Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers.
Vocka, Michal; Zimovjanova, Martina; Bielcikova, Zuzana; Tesarova, Petra; Petruzelka, Lubos; Mateju, Martin; Krizova, Ludmila; Kotlas, Jaroslav; Soukupova, Jana; Janatova, Marketa; Zemankova, Petra; Kleiblova, Petra; Novotny, Jan; Konopasek, Bohuslav; Chodacka, Martina; Brychta, Milan; Sochor, Marek; Smejkalova-Musilova, Denisa; Cmejlova, Vlastimila; Kozevnikovova, Renata; Miskarova, Lenka; Argalacsova, Sona; Stolarova, Lenka; Lhotova, Klara; Borecka, Marianna; Kleibl, Zdenek.
Afiliación
  • Vocka M; Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital, U Nemocnice 499/2, 128 00 Prague 2, Czech Republic. michal.vocka@vfn.cz.
  • Zimovjanova M; Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital, U Nemocnice 499/2, 128 00 Prague 2, Czech Republic. martina.zimovjanova@vfn.cz.
  • Bielcikova Z; Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital, U Nemocnice 499/2, 128 00 Prague 2, Czech Republic. zuzana.bielcikova@vfn.cz.
  • Tesarova P; Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital, U Nemocnice 499/2, 128 00 Prague 2, Czech Republic. petra.tesarova@vfn.cz.
  • Petruzelka L; Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital, U Nemocnice 499/2, 128 00 Prague 2, Czech Republic. lubos.petruzelka@vfn.cz.
  • Mateju M; Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital, U Nemocnice 499/2, 128 00 Prague 2, Czech Republic. martin.mateju@vfn.cz.
  • Krizova L; Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital, U Nemocnice 499/2, 128 00 Prague 2, Czech Republic. ludmila.krizova@vfn.cz.
  • Kotlas J; Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital, Albertov 4, 128 00 Prague 2, Czech Republic. jaroslav.kotlas@vfn.cz.
  • Soukupova J; Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, U Nemocnice 5, 128 00 Prague 2, Czech Republic. jana.soukupova@lf1.cuni.cz.
  • Janatova M; Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, U Nemocnice 5, 128 00 Prague 2, Czech Republic. marketa.janatova@lf1.cuni.cz.
  • Zemankova P; Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, U Nemocnice 5, 128 00 Prague 2, Czech Republic. petra.zemankova@lf1.cuni.cz.
  • Kleiblova P; Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital, Albertov 4, 128 00 Prague 2, Czech Republic. pekleje@lf1.cuni.cz.
  • Novotny J; Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, U Nemocnice 5, 128 00 Prague 2, Czech Republic. pekleje@lf1.cuni.cz.
  • Konopasek B; Department of Surgery, Sunderby Hospital, Sjukhusvägen 10, 954 42 Sunderbyn, Sweden. onkologie@seznam.cz.
  • Chodacka M; Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital, U Nemocnice 499/2, 128 00 Prague 2, Czech Republic. bohuslav.konopasek@vfn.cz.
  • Brychta M; Department of Oncology, Chomutov Hospital, Kochova 1185, 430 01 Chomutov, Czech Republic. martina.chodacka@kzcr.eu.
  • Sochor M; Department of Radiotherapy and Oncology, Third Faculty of Medicine, Charles University and Faculty Hospital Kralovske Vinohrady, Srobarova 1150/50, 100 34 Prague 10, Czech Republic. brychta@fnkv.cz.
  • Smejkalova-Musilova D; Department of Oncology, Vzdusna 1360/6, 460 01 Liberec, Czech Republic. sochor.marek73@gmail.com.
  • Cmejlova V; Department of Oncology, Masaryk Hospital, Socialni pece 3316/12, 401 13 Usti nad Labem, Czech Republic. denisa.smejkalovamusilova@kzcr.eu.
  • Kozevnikovova R; Department of Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, V Uvalu 84, 150 06 Prague 5, Czech Republic. v.cmejlova@seznam.cz.
  • Miskarova L; Department of Oncology, Medicon, Roskotova 1717/2, 140 00 Prague 4, Czech Republic. r.kozevnikovova@email.cz.
  • Argalacsova S; Department of Oncology, First Faculty of Medicine, Charles University and Thomayer Hospital, Videnska 800, 140 59 Prague 4, Czech Republic. lenka.mockova@gmail.com.
  • Stolarova L; Institute of Radiation Oncology, First Faculty of Medicine, Charles University and Hospital Na Bulovce, Budinova 2, 180 00 Prague 8, Czech Republic. argi@centrum.cz.
  • Lhotova K; Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, U Nemocnice 5, 128 00 Prague 2, Czech Republic. lenka.stolarova@lf1.cuni.cz.
  • Borecka M; Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, U Nemocnice 5, 128 00 Prague 2, Czech Republic. klara.lhotova@lf1.cuni.cz.
  • Kleibl Z; Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, U Nemocnice 5, 128 00 Prague 2, Czech Republic. marianna.borecka@lf1.cuni.cz.
Cancers (Basel) ; 11(6)2019 May 28.
Article en En | MEDLINE | ID: mdl-31141992

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2019 Tipo del documento: Article País de afiliación: República Checa

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2019 Tipo del documento: Article País de afiliación: República Checa